mRNA-based cancer therapy

mRNA-based cancer therapy

Topic

Heard in 3 episodes across 2 shows since Aug 2026

mRNA-based cancer therapy is an emerging form of immunotherapy that utilizes messenger RNA technology to stimulate a patient's immune system to target and destroy cancer cells. Often designed as personalized cancer vaccines, these therapies are engineered to produce specific tumor-associated antigens, training the body's adaptive immune response to recognize and attack the patient's unique strain of cancer.

Learn more

Episodes

3
across 2 shows

First heard

Aug 2026

Expert statements

2
1 positive · 1 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20263
Sep 20260
Oct 20260

What experts have said about mRNA-based cancer therapy

2 statements · 1 positive · 1 negative

  1. Tatiana DariaPositiveAug 28, 2026· Stock Movers

    Positive melanoma results raised hopes for mRNA treatments beyond COVID-19.

    “it raised hopes about the mRNA's second act here after COVID.”

    Listen at 3:46

    Open the episode · Paypal Sinks on Abandoned Deal, Affirm Rallies, BioNTech Slumps
  2. Tatiana DariaNegativeAug 28, 2026· Stock Movers

    BioNTech’s setback raises doubts about mRNA technology in solid tumors.

    “this is raising real questions about can this technology work in other tumors, particularly solid tumors”

    Listen at 3:51

    Open the episode · Paypal Sinks on Abandoned Deal, Affirm Rallies, BioNTech Slumps
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

3 episodes featuring mRNA-based cancer therapy, newest first

mRNA-based cancer therapy · PodLume